A scientific review published in Cardio-Oncology examines how the field of cardio-oncology is expanding beyond its traditional focus on cancer therapy–related cardiotoxicity to evaluate cardiovascular disease as an active promoter of tumor development. The authors report that accumulating evidence supports a bidirectional relationship between cardiovascular disorders and cancer, in which underlying cardiovascular pathology actively contributes to tumor progression rather than occurring solely as an unintended complication of oncological treatments.
Epidemiological evidence synthesized in the review demonstrates higher cancer incidence and cancer-related mortality across several distinct cardiovascular disease phenotypes. These conditions include atherosclerosis, hypertension, myocardial infarction, atrial fibrillation, and heart failure. Notably, the elevated cancer risk documented across these clinical populations extends beyond the influence of shared risk factors and common pathophysiological pathways, suggesting distinct disease-driven effects.
Complementing human population studies, experimental research in animal models provides mechanistic clues connecting cardiac injury directly to accelerated cancer progression.
The review identifies several biological mechanisms proposed to mediate this heart-to-tumor crosstalk. These mechanisms include the cardiac secretion of tumor-potentiating proteins and small extracellular vesicles into circulation, systemic immune reprogramming following cardiac injury, and gut microbiome dysbiosis associated with chronic heart failure. Together, these processes suggest diverse routes through which cardiac pathology can generate systemic pro-oncogenic signals.
The authors also observe that the impact of cardiovascular disease on tumor progression is cancer-type-specific and varies across experimental tumor models. This variation highlights substantial biological heterogeneity in heart-to-tumor communication, indicating that different malignancies may respond distinctively to circulating cardiovascular signals.
To explore potential molecular mediators, the researchers conducted an analysis of literature-reported chronic heart failure biomarkers, identifying a specific subset with strong associations across multiple cancer types. Synthesizing epidemiological, experimental, and computational findings, the authors conclude that cardiovascular disease and cancer share a complex and potentially causal relationship, noting that advancing this mechanistic understanding could refine oncological risk stratification in cardiovascular patients and inform targeted strategies to disrupt heart-to-tumor signaling within integrated cardio-oncology care.
Subject of Research: Cardiovascular disease as a potential driver of tumor progression
Article Title: Cardiovascular disease as a driver of tumor development: epidemiological, mechanistic and bioinformatic insights
Article References: van Berlo, B., Guns, P.-J., de Keulenaer, G. W., & Segers, V. F. M. (2026). Cardiovascular disease as a driver of tumor development: epidemiological, mechanistic and bioinformatic insights. Cardio-Oncology. https://doi.org/10.1186/s40959-026-00562-3
Image Credits: AI Generated
DOI: 10.1186/s40959-026-00562-3
Keywords: cardio-oncology, cardiovascular disease, tumor progression, heart failure, cancer biology, biomarkers, atherosclerosis, oncology, Cardiovascular, disease, driver, tumor
News Source: Nathaniel Bowman. (November 8, 2026). Cardiovascular Disease Linked to Accelerated Tumor Development Across Multiple Cancers. Scienmag.



